Abstract: The present invention relates to a mesenchymal stem cell having immunomodulatory activity and a preparation method therefor and, more specifically, to: a rapamycin-treated mesenchymal stem cell having immunomodulatory activity, which expresses any one or more cell surface factors selected from the group consisting of CCR1, CCR2, CCR3, CCR4, CCR7, CCR9 and CXCR4; a cell therapy composition comprising the mesenchymal stem cell, for preventing or treating immune disorders; and a preparation method for the mesenchymal stem cell having immunomodulatory activity. The rapamycin-treated mesenchymal stem cell having immunomodulatory activity, according to the present invention, has increased expression of IDO, TGF-? and IL-10 which are factors having immunomodulatory activity, has decreased expression of Phospho-mTOR, Rictor and Ractor which are signal transduction factors of mTOR, and has increased expression, in the cell, of autophagic inducer Beclin1, ATG5, ATG7, LC3I or LCII.

Abstract: An apparatus for correcting option misjudgment of a control unit includes a location information searcher for generating location information of a vehicle. The control unit changes and applies an option value of the vehicle in response to an abnormal mode when a current location of the location information is in the abnormal mode.

Abstract: An apparatus for correcting option misjudgment of a control unit includes a location information searcher for generating location information of a vehicle. The control unit changes and applies an option value of the vehicle in response to an abnormal mode when a current location of the location information is in the abnormal mode.

Abstract: The present invention relates to a mesenchymal stem cell having immunomodulatory activity and a preparation method therefor and, more specifically, to: a rapamycin-treated mesenchymal stem cell having immunomodulatory activity, which expresses any one or more cell surface factors selected from the group consisting of CCR1, CCR2, CCR3, CCR4, CCR7, CCR9 and CXCR4; a cell therapy composition comprising the mesenchymal stem cell, for preventing or treating immune disorders; and a preparation method for the mesenchymal stem cell having immunomodulatory activity. The rapamycin-treated mesenchymal stem cell having immunomodulatory activity, according to the present invention, has increased expression of IDO, TGF-? and IL-10 which are factors having immunomodulatory activity, has decreased expression of Phospho-mTOR, Rictor and Ractor which are signal transduction factors of mTOR, and has increased expression, in the cell, of autophagic inducer Beclin1, ATG5, ATG7, LC3I or LCII.

Abstract: A vehicle lamp autocut apparatus and method are provided. The vehicle lamp autocut method includes acquiring, by a controller, current positional information of a vehicle when a power supply of the vehicle is turned off and detecting whether the vehicle is safe based on the current positional information. In addition, the controller is configured to detect whether a lamp within the vehicle is a turn on state when the vehicle is safe and whether a vehicle state satisfies a lamp turn off condition when the lamp is in the turn on state. The lamp is turned off when the vehicle state satisfies the lamp off condition, thereby preventing a battery of a vehicle from being discharged.

Abstract: The present invention relates to a composition comprising GRIM-19 protein as an active ingredient for preventing or treating obesity or lipid-related metabolic diseases. More particularly, the present invention relates to a composition for preventing or treating obesity or lipid-related metabolic diseases wherein the composition comprises GRIM-19 protein as an active ingredient for preventing or treating metabolic diseases caused by immune response disorders or interactions between genetic, metabolic, or environmental complex factors. The GRIM-19 protein according to the present invention exhibits excellent effectiveness not only in reducing lipocytes and total cholesterol content in the body, but also in suppressing the differentiation of cytotoxic Th17 cells that produce and secrete inflammatory cytokines. Also, GRIM-19 has been found to have excellent effectiveness in regulating a STAT3 mediated inflammatory response in an inflammatory environment related to obesity.

Abstract: A vehicle lamp autocut apparatus and method are provided. The vehicle lamp autocut method includes acquiring, by a controller, current positional information of a vehicle when a power supply of the vehicle is turned off and detecting whether the vehicle is safe based on the current positional information. In addition, the controller is configured to detect whether a lamp within the vehicle is a turn on state when the vehicle is safe and whether a vehicle state satisfies a lamp turn off condition when the lamp is in the turn on state. The lamp is turned off when the vehicle state satisfies the lamp off condition, thereby preventing a battery of a vehicle from being discharged.